CA
NZ
UK
AU
IND
US
Accenture (NYSE: ACN) has made a strategic investment in GoUpscale, a technology firm focused on content engagement for wealth management firms in Asia. The investment was made through Accenture Ventures and is part of Accenture’s broader focus on digital innovation within the financial services …
CMB.TECH NV (NYSE: CMBT & Euronext: CMBT) has signed a charter agreement with Fortescue for a 210,000-deadweight ton (dwt) Newcastlemax dry bulk vessel powered by ammonia. The agreement involves Bocimar, the shipping division of CMB.TECH, and forms part of a larger fleet currently under …
Safe Bulkers, Inc. (NYSE: SB)is a holding company focused on acquiring, owning, and operating drybulk vessels. Its fleet transports drybulk cargo globally, serving the marine transportation industry.
US stock futures rose between 0.7% and 1%, rebounding from the previous session’s sharp losses, supported by strong bank earnings. JPMorgan reported record Q1 revenues, while BlackRock, Wells Fargo, and BNY Mellon also exceeded profit expectations. Despite the bounce, bond markets continued to decline …
Shares of NIKE, Inc. (NYSE:NKE) slid to a new 52-week low of $52.28 on Friday, ending the day at $54.41 as investor confidence waned following a Stifel Nicolaus downgrade, which lowered the stock’s price target from $75 to $64 while maintaining aholdrating. The decline …
A new report from Homes.com, a leading online residential marketplace owned by CoStar Group, reveals that while U.S. home prices continued to climb in March 2025, the pace of appreciation slowed for the third month in a row—signaling a possible turning point in the …
The U.S. Food and Drug Administration (FDA) has approved the VYVGART® Hytrulo prefilled syringe for self-injection, offering a new level of convenience and autonomy for adult patients diagnosed with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive, as well as those …
Pharmaceutical giant Novartis (NYSE:NVS) announced on Thursday that it will invest $23 billion over the next five years to significantly expand its U.S. operations, reinforcing its commitment to American drug manufacturing as the industry faces growing uncertainty over potential tariffs.
MSP Recovery, Inc. (NASDAQ:MSPR), a leading technology-driven platform for recovering Medicare, Medicaid, commercial, and secondary payer claims, has announced a comprehensive restructuring initiative aimed at significantly boosting its financial position and sharpening its operational focus.
S&P 500 and Nasdaq 100 contracts down over 2% and Dow futures falling around 670 points, following Wednesday’s major rally. The drop reflects lingering concerns despite President Trump’s 90-day tariff pause for most trade partners, as steep tariffs on China remain. Market volatility is …
Please wait processing your request...